Deals Of The Week: Lilly/Cadila, Genzyme/Bayer, Lilly/Amylin/Altea ...
Executive Summary
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.
You may also be interested in...
Proxy War-Front Latest: Amylin, Vanda Rocked By Dissident Shareholders
In tough times, patience for failing drugs and restructuring programs wears particularly thin.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011